0.294
-0.09 (-23.87%)
| Penutupan Terdahulu | 0.386 |
| Buka | 0.300 |
| Jumlah Dagangan | 259,221 |
| Purata Dagangan (3B) | 206,315 |
| Modal Pasaran | 6,302,010 |
| Harga / Jualan (P/S) | 291.47 |
| Harga / Buku (P/B) | 1.15 |
| Julat 52 Minggu |
| Margin Operasi (TTM) | -11,739.09% |
| EPS Cair (TTM) | -0.060 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -87.00% |
| Nisbah Semasa (MRQ) | 0.270 |
| Aliran Tunai Operasi (OCF TTM) | -1.24 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -1.25 M |
| Pulangan Atas Aset (ROA TTM) | -61.74% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Instruments & Supplies (US) | Bercampur | Bercampur |
| Medical Instruments & Supplies (Global) | Bercampur | Menurun | |
| Stok | Cuprina Holdings (Cayman) Limit | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -0.5 |
| Purata | -0.63 |
|
Cuprina Holdings (Cayman) Ltd is a biomedical and biotechnology company that is dedicated to the development and commercialization of products for the management of chronic wounds, as well as operating in the health and beauty sector. It manufactured and distributed a line of medical grade sterile blowfly larvae bio-dressing products marketed under the MEDIFLY brand name, or the MEDIFLY products. The MEDIFLY products are used as a biological debridement tool for chronic wounds, in a procedure known as Maggot Debridement Therapy, or MDT, which is an effective alternative to surgical debridement. |
|
| Sektor | Healthcare |
| Industri | Medical Instruments & Supplies |
| Gaya Pelaburan | Small Value |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Prospect Financial Group Llc | 31 Dec 2025 | 24,932 |
| Stonex Group Inc. | 31 Dec 2025 | 0 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |